# TB-500 Hair Growth and Follicle Stem-Cell Research: The Thymosin Beta-4 Record > TB-500 hair growth research, sourced: thymosin beta-4 activated hair-follicle bulge stem cells in rodents (Philp 2004, FASEB), with corroborating mouse data. No human hair data for the fragment. The hair-follicle literature attached to the TB-500 name — what was shown, in which rodents, and where the human channel drops out. ## The hair-follicle finding TB-500 hair growth interest traces to a single well-cited rodent finding about the parent protein. thymosin beta-4 at nanomolar concentrations stimulated hair growth in normal rats and mice by activating hair-follicle bulge stem cells — increasing their migration and differentiation and enhancing MMP-2 expression in the follicle [7]. The result was published in FASEB Journal in 2004 and framed hair growth as one expression of thymosin beta-4's broader cell-migration biology. The same group restated the mechanism in a later report, describing thymosin beta-4 inducing hair growth via stem-cell migration and differentiation [8]. An independent mouse study then corroborated the effect, reporting that thymosin beta-4 induced mouse hair growth [9]. A combined-effects study placed hair-follicle development alongside angiogenesis and wound healing as concurrent thymosin beta-4 activities [11], and a 2021 review surveyed the multiple potential roles of thymosin beta-4 in hair-follicle growth and development [10]. Every one of those results is a full-length thymosin beta-4 result, in rodents. None of them is a TB-500 fragment result, and none of them is human. ## Why the bulge matters The bulge region of the hair follicle holds the stem cells that supply the lower follicle during each growth cycle. The proposed mechanism in these studies is mobilization: thymosin beta-4, an actin-binding peptide that drives cell migration, increases the migration and differentiation of those bulge cells and raises MMP-2, an enzyme that remodels the surrounding matrix to let cells move [7]. In other words, the hair effect is read as a special case of the same migration biology described on the [actin-sequestration mechanism](/research) page. Because TB-500 carries the LKKTETQ actin-binding motif, the mechanistic rationale for a fragment effect is plausible on paper. Plausible-on-paper is not the same as demonstrated, and the fragment has not been tested for hair growth in any controlled study. ## How the hair finding fits the wider repair literature The hair result is not an isolated curiosity; it sits inside thymosin beta-4's general role in cell migration and tissue repair. The same 2004 group that reported the follicle effect also published a combined-effects study placing hair-follicle development alongside angiogenesis and wound healing as concurrent activities of the protein [11], and a broad regenerative-peptide review frames all of these as expressions of one underlying biology — actin binding, cell mobilization, and reduced scarring [5]. The 2021 review is the most useful single entry for readers who want the hair-specific picture. It surveys the multiple potential roles of thymosin beta-4 in hair-follicle growth and development, gathering the bulge-stem-cell, MMP, and angiogenesis threads into one account [10]. Read together, the literature describes a coherent, repeatedly observed rodent phenomenon — and says nothing, anywhere, about the isolated Ac-LKKTETQ fragment in a human follicle. A dermal-healing review rounds out the skin context: thymosin beta-4 promotes skin wound repair generally [12], and hair-follicle stem cells are part of that same skin-and-appendage repair system. So the hair finding is mechanistically plausible and well company-kept within the protein's biology. None of that supporting context, however, converts a rodent full-length-protein result into a demonstrated human fragment effect. ## Where the human data stop No human hair-growth data exist for the TB-500 heptapeptide. The rodent findings are consistent and come from more than one laboratory, which is a genuine strength of the preclinical record [7][9]. But hair-growth biology does not always translate from rodents to humans, and the molecule actually studied in those papers — full-length thymosin beta-4 — is not the molecule sold as TB-500 [5]. What would close the gap is specific and currently missing: a controlled study of the Ac-LKKTETQ fragment, in human follicles or in people, measured against a comparator. Until something like that exists, the honest position is that the fragment's hair effect is untested, not established and not refuted. The rodent protein data cannot stand in for it, because the two molecules differ in mass, in domain content, and in everything downstream of the shared actin-binding motif [5]. This page therefore reports a real, reproducible animal finding and an honest gap in the same breath. The strongest accurate sentence is the careful one: nanomolar thymosin beta-4 activated hair-follicle bulge stem cells in rats and mice [7], and the human relevance of that for the Ac-LKKTETQ fragment is, at present, unproven [5]. --- A chromatic-split scope reading of the TB-500 record — the Ac-LKKTETQ fragment held on one channel and full-length thymosin beta-4 on the other so the two are never mistaken for one trace, the FDA 503A standing read before anything else, with no clinic behind the scope and nothing here dispensed or sold.